Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Saved in:
| Title: | Cannabidiol for the treatment of autism spectrum disorder: hope or hype? |
|---|---|
| Authors: | Pedrazzi JFC; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. joaofranciscopedrazzi@usp.br., Ferreira FR; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, 21040-900, Brazil., Silva-Amaral D; Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Lima DA; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Hallak JEC; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Zuardi AW; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Del-Bel EA; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Morphology, Physiology, and Basic Pathology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Guimarães FS; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Costa KCM; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Campos AC; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Crippa ACS; Graduate Program in Child and Adolescent Health, Neuropediatric Center of the Hospital of Clinics (CENEP), Federal University of Paraná, Curitiba, Paraná, Brazil., Crippa JAS; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. |
| Source: | Psychopharmacology [Psychopharmacology (Berl)] 2022 Sep; Vol. 239 (9), pp. 2713-2734. Date of Electronic Publication: 2022 Jul 29. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35904579 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cannabidiol for the treatment of autism spectrum disorder: hope or hype? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pedrazzi+JFC%22">Pedrazzi JFC</searchLink>; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. joaofranciscopedrazzi@usp.br.<br /><searchLink fieldCode="AU" term="%22Ferreira+FR%22">Ferreira FR</searchLink>; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, 21040-900, Brazil.<br /><searchLink fieldCode="AU" term="%22Silva-Amaral+D%22">Silva-Amaral D</searchLink>; Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Lima+DA%22">Lima DA</searchLink>; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Hallak+JEC%22">Hallak JEC</searchLink>; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Zuardi+AW%22">Zuardi AW</searchLink>; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Del-Bel+EA%22">Del-Bel EA</searchLink>; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.; Department of Morphology, Physiology, and Basic Pathology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Guimarães+FS%22">Guimarães FS</searchLink>; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Costa+KCM%22">Costa KCM</searchLink>; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Campos+AC%22">Campos AC</searchLink>; Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Crippa+ACS%22">Crippa ACS</searchLink>; Graduate Program in Child and Adolescent Health, Neuropediatric Center of the Hospital of Clinics (CENEP), Federal University of Paraná, Curitiba, Paraná, Brazil.<br /><searchLink fieldCode="AU" term="%22Crippa+JAS%22">Crippa JAS</searchLink>; Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227608025%22">Psychopharmacology</searchLink> [Psychopharmacology (Berl)] 2022 Sep; Vol. 239 (9), pp. 2713-2734. <i>Date of Electronic Publication: </i>2022 Jul 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7608025 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-2072 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200333158%22">00333158 </searchLink><i>NLM ISO Abbreviation: </i>Psychopharmacology (Berl) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35904579 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00213-022-06196-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2713 Titles: – TitleFull: Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pedrazzi JFC – PersonEntity: Name: NameFull: Ferreira FR – PersonEntity: Name: NameFull: Silva-Amaral D – PersonEntity: Name: NameFull: Lima DA – PersonEntity: Name: NameFull: Hallak JEC – PersonEntity: Name: NameFull: Zuardi AW – PersonEntity: Name: NameFull: Del-Bel EA – PersonEntity: Name: NameFull: Guimarães FS – PersonEntity: Name: NameFull: Costa KCM – PersonEntity: Name: NameFull: Campos AC – PersonEntity: Name: NameFull: Crippa ACS – PersonEntity: Name: NameFull: Crippa JAS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2022 Sep Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1432-2072 Numbering: – Type: volume Value: 239 – Type: issue Value: 9 Titles: – TitleFull: Psychopharmacology Type: main |
| ResultId | 1 |